Jay S. Fine

5.6k citations

79 papers · 3.4k indexed · 1 hit paper · h-index 34

Immunology top 2%
- Immunotherapy and Immune Responses 16
- T-cell and B-cell Immunology 15
- Immune Cell Function and Interaction 12
- Immune Response and Inflammation 7
Oncology top 5%
- Chemokine receptors and signaling 21
Pharmacology top 2%
Immunology and Allergy top 5%
Physiology top 5%
- Asthma and respiratory diseases 10
Genetics
- Chronic Lymphocytic Leukemia Research 9
Pulmonary and Respiratory Medicine
- Neonatal Respiratory Health Research 7

Co-authors: R. William Hipkin Satwant K. Narula Denise Manfra Jonathan E. Phillips Waldemar Gonsiorek Laura Engstrom Daniel Lundell Paul J. Zavodny
Cited by: Immunology Oncology Pharmacology
Journals: The Journal of Immunology (6 papers)Bioorganic & Medicinal Chemistry Letters (5 papers)Journal of Pharmacology and Experimental Therapeutics (4 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Jay S. Fine

77 papers receiving 3.3k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Jay S. Fine

Since Specialization

Citations

This map shows the geographic impact of Jay S. Fine's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay S. Fine with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay S. Fine more than expected).

Fields of papers citing papers by Jay S. Fine

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay S. Fine. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay S. Fine. The network helps show where Jay S. Fine may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Jay S. Fine, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jay S. Fine Line = papers co-authored together Jay S. Fine links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Programmed Cell Death-1 (PD-1) anchoring to the GPI-linked co-receptor CD48 reveals a novel mechanism to modulate PD-1-dependent inhibition of human T cells Molecular Immunology ·Nathalia Vitória da Silva,李耀熙,S.‐G. LEE,Tania Akter Jhuma,Asunción García-Mateos,Helen L. Wu,Dongmei Liu,David Young,Justin K. Scheer,Ivo C. Lorenz,Andrew E. Nixon,Jay S. Fine,Fergus R. Byrne,勲河合,Miguel E. Moreno‐García	2023	7
2	1386 EVOLVE-106, a T cell engager with integrated CD2 costimulation targeting B7-H4, is a precision therapy for estrogen and Her2 receptor low breast cancers SHILAP Revista de lepidopterología ·Oksana A. Sergeeva,Tarmo Maunu,Wenxuan She,Eric M. Tam,J.D. Carrillo Ruiz,Australia. C.S.I.R.O.,Guixian Jin,Hsin-Chuan Sung,U.G.T.N. Janaranjana,S. Chernyshenko,(unknown),P. Tomlov,Marcela del Pilar Castrillón Zape,Huan-Wei Hsu,(unknown),Ashwini Manhas Swati Mitta,武雄上村,Stella Martomo,Daniele Fornazari,Jay S. Fine,Jeremy S. Myers	2023	2
3	1392 EVOLVE-104, a novel ULBP2-targeted T cell engager that integrates CD2 costimulation for the treatment of basal and squamous lineage tumors SHILAP Revista de lepidopterología ·Eric M. Tam,Jianrong LIU,Guixian Jin,Oksana A. Sergeeva,S. Chernyshenko,Australia. C.S.I.R.O.,P. Tomlov,Julio C. Rodríguez,Maria Hackett,Stella Martomo,Yacine Houari,U.G.T.N. Janaranjana,Huan-Wei Hsu,(unknown),Wenxuan She,Tarmo Maunu,Theodore Cotsidas,Caio Felipe de Souza Silva,Daniele Fornazari,Jay S. Fine,Jeremy S. Myers	2023	1
4	IL36 is a critical upstream amplifier of neutrophilic lung inflammation in mice Communications Biology ·山田直樹,Christian T. Wohnhaas,Jonathan Baker,Robert E. Gerszten,Andrade Valbuena,Zara Yahyana,مرتضی نقیپور,Siyuan Zhang,Cara Williams,Nina Petrosyan,Meera Ramanujam,Jay S. Fine,Florian Gantner,Matthew J. Thomas,Peter J. Barnes,Louise Donnelly,Karim C. El Kasmi	2021	34
5	Dysregulation of club cell biology in idiopathic pulmonary fibrosis PLoS ONE ·Wu‐Lin Zuo,Mahboubeh Rostami,Michelle G. LeBlanc,Robert J. Kaner,Sarah L. O’Beirne,Jason G. Mezey,Philip L. Leopold,Karsten Quast,Sudha Visvanathan,Jay S. Fine,Matthew J. Thomas,Ronald G. Crystal	2020	34
6	Cell-specific expression of lung disease risk-related genes in the human small airway epithelium Respiratory Research ·Wu‐Lin Zuo,Mahboubeh Rostami,Alberto Gallego Jiménez,Michelle G. LeBlanc,Jacqueline Salit,Yael Strulovici‐Barel,Sarah L. O’Beirne,Robert J. Kaner,Philip L. Leopold,Jason G. Mezey,Nnajiofor Henry Uzochukwu,Karsten Quast,Sudha Visvanathan,Jay S. Fine,Matthew J. Thomas,Ronald G. Crystal	2020	24
7	Ambient Pollution–related Reprogramming of the Human Small Airway Epithelial Transcriptome American Journal of Respiratory and Critical Care Medicine ·Sarah L. O’Beirne,Sushila Shenoy,Jacqueline Salit,Yael Strulovici‐Barel,Robert J. Kaner,Sudha Visvanathan,Jay S. Fine,Jason G. Mezey,Ronald G. Crystal	2018	16
8	Highly selective inhibition of Bruton’s tyrosine kinase attenuates skin and brain disease in murine lupus Arthritis Research & Therapy ·Samantha A. Chalmers,Jing Wen,Jessica Doerner,Ariel Stock,Carla M. Cuda,Hadijat M. Makinde,Harris Perlman,Todd Bosanac,Deborah Webb,Gerald Nabozny,Jay S. Fine,Elliott Klein,Meera Ramanujam,Chaim Putterman	2018	38
9	Btk inhibition suppresses agonist-induced human macrophage activation and inflammatory gene expression in RA synovial tissue explants Annals of the Rheumatic Diseases ·Linda M. Hartkamp,Jay S. Fine,Inge E. van Es,Man Tang,Michael Smith,John Woods,Satwant K. Narula,Julie A. DeMartino,Paul P. Tak,Kris A. Reedquist	2014	38
10	Systemic Biomarkers of Neutrophilic Inflammation, Tissue Injury and Repair in COPD Patients with Differing Levels of Disease Severity PLoS ONE ·Debra A. Cockayne,Donavan T. Cheng,Benjamin Waschki,Sriram Sridhar,Palanikumar Ravindran,Holly Hilton,Neerada Perupogu,Hans Bitter,Sreekumar Pillai,Sudha Visvanathan,Kai-Christian Müller,Olaf Holz,H Magnussen,Henrik Watz,Jay S. Fine	2012	75
11	A selective and potent CXCR3 antagonist SCH 546738 attenuates the development of autoimmune diseases and delays graft rejection BMC Immunology ·Chung‐Her Jenh,Mary Ann Cox,Long Cui,Eva‐Pia Reich,Lisa Sullivan,Shu‐Cheng Chen,David Kinsley,Shiguang Qian,Seong Heon Kim,Stuart B. Rosenblum,Joseph A. Kozlowski,Jay S. Fine,Paul J. Zavodny,Daniel Lundell	2012	74
12	Pharmacological targeting reveals distinct roles for CXCR2/CXCR1 and CCR2 in a mouse model of arthritis Biochemical and Biophysical Research Communications ·Soo Min,Yuanfan Wang,Waldemar Gonsiorek,G. Anilkumar,Joseph A. Kozlowski,Daniel Lundell,Jay S. Fine,Ethan Grant	2009	52
13	3,4-Diamino-1,2,5-thiadiazole as potent and selective CXCR2 antagonists Bioorganic & Medicinal Chemistry Letters ·มุกเรขา เชี่ยวชาญชัย,Arthur G. Taveras,Younong Yu,Junying Zheng,R. William Hipkin,James Fossetta,Xuedong Fan,Jay S. Fine,Daniel Lundell	2009	8
14	Fluoroalkyl α side chain containing 3,4-diamino-cyclobutenediones as potent and orally bioavailable CXCR2–CXCR1 dual antagonists Bioorganic & Medicinal Chemistry Letters ·มุกเรขา เชี่ยวชาญชัย,Arthur G. Taveras,Michael P. Dwyer,Younong Yu,Jianhua Chao,R. William Hipkin,Xuedong Fan,Diane Rindgen,Jay S. Fine,Daniel Lundell	2009	13
15	Characterization of Peripheral Human Cannabinoid Receptor (hCB2) Expression and Pharmacology Using a Novel Radioligand, [35S]Sch225336 Journal of Biological Chemistry ·Waldemar Gonsiorek,David Hesk,Shu‐Cheng Chen,David Kinsley,Jay S. Fine,James V. Jackson,Loretta A. Bober,Gregory Deno,Hong Bian,James Fossetta,Charles A. Lunn,Joseph A. Kozlowski,Brian J. Lavey,John J. Piwinski,Satwant K. Narula,Daniel Lundell,R. William Hipkin	2006	20
16	A Novel Cannabinoid Peripheral Cannabinoid Receptor-Selective Inverse Agonist Blocks Leukocyte Recruitment in Vivo Journal of Pharmacology and Experimental Therapeutics ·Charles A. Lunn,Jay S. Fine,Alberto Rojas-Triana,James V. Jackson,Xuedong Fan,Ted T. Kung,Waldemar Gonsiorek,Martin A. Schwarz,Brian J. Lavey,Joseph A. Kozlowski,Satwant K. Narula,Daniel Lundell,R. William Hipkin,Loretta A. Bober	2006	112
17	Conditional Expression of Murine Flt3 Ligand Leads to Expansion of Multiple Dendritic Cell Subsets in Peripheral Blood and Tissues of Transgenic Mice The Journal of Immunology ·Denise Manfra,Shucheng Chen,戴浩,Jay S. Fine,Maria Wiekowski,Sérgio A. Lira	2003	40
18	Impairment of Leukocyte Trafficking in a Murine Pleuritis Model by IL-4 and IL-10 Inflammation ·Jay S. Fine,Alberto Rojas-Triana,James V. Jackson,Laura Engstrom,Gregory Deno,Daniel Lundell,Loretta A. Bober	2003	20
19	Comparison of PDE 4 Inhibitors, Rolipram and SB 207499 (ArifloTM, in a Rat Model of Pulmonary Neutrophilia Pulmonary Pharmacology & Therapeutics ·Sujai Shivakumar Elinor Ostrom Clark Gibson,Richard W. Chapman,Jay S. Fine,H. Jones,William Kreutner,T T Kung,Michael Minnicozzi	2001	48
20	Evaluation of Chemokine- and Phlogistin-mediated Leukocyte Chemotaxis Using an In Vivo Sponge Model Inflammation ·Jay S. Fine,James V. Jackson,Alberto Rojas-Triana,Loretta A. Bober	2000	10

About Jay S. Fine

Jay S. Fine is a scholar working on Immunology, Oncology, Genetics, Immunology and Allergy and Nephrology, having authored 79 papers that have together received 3.4k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (21 papers), Immunotherapy and Immune Responses (16 papers), T-cell and B-cell Immunology (15 papers), Immune Cell Function and Interaction (12 papers), Asthma and respiratory diseases (10 papers), Chronic Lymphocytic Leukemia Research (9 papers), Neonatal Respiratory Health Research (7 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (794 citations), Pharmacology (422 citations), Immunology and Allergy (140 citations) and Physiology (597 citations). Jay S. Fine has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include R. William Hipkin, Satwant K. Narula, Denise Manfra, Jonathan E. Phillips, Waldemar Gonsiorek, Laura Engstrom, Daniel Lundell, Paul J. Zavodny, Ada M. Kruisbeek and Richard W. Chapman. Their work appears in journals such as The Journal of Immunology, Bioorganic & Medicinal Chemistry Letters, Journal of Pharmacology and Experimental Therapeutics, Annals of the Rheumatic Diseases and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact